Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Azilect

PreclinicalSmall molecule

1

Indications

6

Total Trials

0

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

ALKUnknown status

ALKPreclinical

Unknown status

Clinical

Trials by Indication[1]

Parkinson's Disease2 trials

Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea

Completed· Lundbeck logo

Lundbeck·Phase 3·NCT01268891·132 enrolled

Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline

Completed·TTechnische Universität Dresden·Phase 4·NCT00902941·34 enrolled

Parkinson's1 trial

Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China

Completed· Lundbeck logo

Lundbeck·Phase 3·NCT01479530·321 enrolled

ALK1 trial

Ambulosono Rasagiline Musical Walking Study

Unknown status·UUniversity of British Columbia·N/A·NCT02207387·60 enrolled

Apathy1 trial

Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study

Unknown status·UUniversity Hospital, Clermont-Ferrand·Phase 4·NCT01765257·50 enrolled

Unspecified1 trial

Azilect® In Wearing-Off (AIWO)

Completed· Teva logo

Teva··NCT02384512·261 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Azilect. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Azilect compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Azilect. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Lundbeck company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Lundbeck

Related News